Implication of Mineralocorticoid Receptor Antagonist Esaxerenone in Patients With Heart Failure With Preserved Ejection Fraction

Background: The implications of mineralocorticoid receptor antagonists, including the newly introduced esaxerenone, on cardiac reverse remodeling in patients with heart failure with preserved ejection fraction (HFpEF) remain uncertain. Methods and Results: We included patients with HFpEF who receive...

Descripción completa

Detalles Bibliográficos
Autores principales: Imamura, Teruhiko, Oshima, Akira, Narang, Nikhil, Kinugawa, Koichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Circulation Society 2021
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8578130/
https://www.ncbi.nlm.nih.gov/pubmed/34805606
http://dx.doi.org/10.1253/circrep.CR-21-0115

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8578130/
https://www.ncbi.nlm.nih.gov/pubmed/34805606
http://dx.doi.org/10.1253/circrep.CR-21-0115

Ejemplares similares